Blog
RSS FeedPosted by Michael Wonder on 24 Jun 2019
England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right
21 June 2019 - NHS England’s chief executive Simon Stevens was in Manchester this week at the NHS Confederation conference, ...
Posted by Michael Wonder on 20 Jun 2019
Innovative treatment for inflammatory eye condition recommended for use on the NHS
20 June 2019 - People with recurrent non-infectious uveitis affecting the back of the eye could benefit from a new treatment ...
Posted by Michael Wonder on 19 Jun 2019
Game-changing cancer drugs which can attack all tumours will be fast-tracked by NHS
19 June 2019 - Game-changing cancer drugs which can attack all types of tumour will be fast-tracked by the NHS, ...
Posted by Michael Wonder on 19 Jun 2019
NICE nod for Blincyto
19 June 2019 - NICE has announced the recommendation of Amgen’s Blincyto (blinatumomab) for treating acute lymphoblastic leukaemia. ...
Posted by Michael Wonder on 19 Jun 2019
Department of Health and Social Care seeks new Chair to lead NICE Board
19 June 2019 - Applications must be received by midday on 22 July 2019. ...
Posted by Michael Wonder on 18 Jun 2019
Buyers’ Club wants government support on Orkambi imports
17 June 2019 - Proposes three point plan to work round impasse. ...
Posted by Michael Wonder on 17 Jun 2019
Population adjustment methods for indirect comparisons: A review of NICE Technology Appraisals
13 June 2019 - Indirect comparisons via a common comparator (anchored comparisons) are commonly used in health technology assessment. However, ...
Posted by Michael Wonder on 15 Jun 2019
Theresa May tells drugs firm to make a deal and end misery
13 June 2019 - Prime Minister Theresa May told MPs that the deal being proposed... a £108million-a-year contract... was fair and ...
Posted by Michael Wonder on 11 Jun 2019
MPs to debate cystic fibrosis drug Orkambi in Parliament
10 June 2019 - A debate is due to take place in Westminster about a drug for people living with ...
Posted by Michael Wonder on 11 Jun 2019
Orkambi row: government now considering Crown Use licensing
11 June 2019 - MPs call for radical solutions as deadlock remains. ...
Posted by Michael Wonder on 10 Jun 2019
Not playing NICE: UK drugs gatekeeper in US crosshairs
10 June 2019 - The U.S. wants Britain to buy more of its drugs after Brexit — but it also ...
Posted by Michael Wonder on 05 Jun 2019
NHS publishes update on the use of biosimilars
5 June 2019 - The United Kingdom’s National Health Service (NHS) has published a new document for clinical and nonclinical ...
Posted by Michael Wonder on 05 Jun 2019
Families create buyers club for cut-price cystic fibrosis drug
5 June 2019 - Stalemate in NHS talks over Orkambi leads parents to buy generic version from Argentina. ...
Posted by Michael Wonder on 30 May 2019
NICE backs Merck's Prevymis for CMV
30 May 2019 - NICE has published its final appraisal document for the use of Merck's Prevymis (letermovir/ID1153) in preventing ...
Posted by Michael Wonder on 28 May 2019
UK refuses to back 'game-changing' resolution on drug pricing
28 May 2019 - Global agreement urges governments to share information on actual cost of medicines, with aim of making them ...